NCT07098806: Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 24 planned
- Started
- 2 Jul 2025
- Primary completion
- 31 Jul 2027
- Arms
- Experimental: Multiple Doses
- Results
- None posted
- 2 Jul 2025: Trial started
- 1 Aug 2025: Trial registered